APH vs. SPI, ESP, RTN, IPF, SGM, MSI, MCP, BERI, AMAT, and STM
Should you be buying Alliance Pharma stock or one of its competitors? The main competitors of Alliance Pharma include Spire Healthcare Group (SPI), Empiric Student Property (ESP), The Restaurant Group (RTN), International Personal Finance (IPF), Sigma Capital Group (SGM), MS INTERNATIONAL (MSI), Martin Currie Asia Unconstrand Trust (MCP), BlackRock Energy and Resources (BERI), Amati AIM VCT (AMAT), and STM Group (STM). These companies are all part of the "electronic equipment" industry.
Alliance Pharma vs.
Spire Healthcare Group (LON:SPI) and Alliance Pharma (LON:APH) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, community ranking, analyst recommendations, earnings and valuation.
50.4% of Spire Healthcare Group shares are owned by institutional investors. Comparatively, 66.3% of Alliance Pharma shares are owned by institutional investors. 34.7% of Spire Healthcare Group shares are owned by company insiders. Comparatively, 12.0% of Alliance Pharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Spire Healthcare Group pays an annual dividend of GBX 3 per share and has a dividend yield of 1.3%. Alliance Pharma pays an annual dividend of GBX 2 per share and has a dividend yield of 4.4%. Spire Healthcare Group pays out 4,285.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Alliance Pharma pays out -3,333.3% of its earnings in the form of a dividend. Alliance Pharma is clearly the better dividend stock, given its higher yield and lower payout ratio.
In the previous week, Spire Healthcare Group and Spire Healthcare Group both had 1 articles in the media. Spire Healthcare Group's average media sentiment score of 0.88 beat Alliance Pharma's score of 0.75 indicating that Spire Healthcare Group is being referred to more favorably in the media.
Spire Healthcare Group has higher revenue and earnings than Alliance Pharma. Alliance Pharma is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.
Spire Healthcare Group currently has a consensus price target of GBX 322, suggesting a potential upside of 44.07%. Alliance Pharma has a consensus price target of GBX 60, suggesting a potential upside of 30.51%. Given Spire Healthcare Group's higher probable upside, analysts clearly believe Spire Healthcare Group is more favorable than Alliance Pharma.
Spire Healthcare Group has a net margin of 1.96% compared to Alliance Pharma's net margin of -18.34%. Spire Healthcare Group's return on equity of 4.00% beat Alliance Pharma's return on equity.
Spire Healthcare Group has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500. Comparatively, Alliance Pharma has a beta of 0.67, suggesting that its stock price is 33% less volatile than the S&P 500.
Spire Healthcare Group received 152 more outperform votes than Alliance Pharma when rated by MarketBeat users. However, 62.08% of users gave Alliance Pharma an outperform vote while only 60.89% of users gave Spire Healthcare Group an outperform vote.
Summary
Spire Healthcare Group beats Alliance Pharma on 12 of the 18 factors compared between the two stocks.
Get Alliance Pharma News Delivered to You Automatically
Sign up to receive the latest news and ratings for APH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alliance Pharma Competitors List
Related Companies and Tools
This page (LON:APH) was last updated on 12/21/2024 by MarketBeat.com Staff
Free APH Stock Alerts